Reverse primer: CCGAACTTGCTGCAGACTCT). The relative abundance of each of these target transcripts was normalized to the expression level of HPRT1 (HS_HPRT1_1_SG), assessed using the CFX Maestro software.
STAT-1 phosphorylation
Peripheral blood mononuclear cells (PBMCs) were isolated from blood collected into Falcon tubes (Thermo Fisher Scientific) containing 35 U preservative-free heparin (CP Pharmaceuticals) per 50 ml. Blood was the diluted with the equal volume of RPM1640 medium and overlaid on an equal volume of Ficoll-Paque reagent, and then centrifuged 800 g for 10 min with the brake off. The PBMC layer was taken, washed and resuspended in warm RPMI with 10% FCS. PBMC were stimulated with 5 ng/ml of IFN-α for 30 minutes. Cells were fixed using BD Cell Fix Buffer (10 min at 37 o C) and then permeabilized using BD PermIII Buffer (30min at 4°C). Cells were stained with PE-anti-STAT1 (BD Bioscience, cat: 612564, pY701, 1:50) and other cell surface markers BV711-CD4 (Biolegend, cat: 317440, OKT4, 1:100), BV605-CD14 (Biolegend, cat: 301833, M5E2, 1:100) and BV510-CD8a (Biolegend, cat: 301048, RPA-T8, 1:100) for 1h at room temperature protected from light.
Flow cytometry analysis was performed on a BD LSRII flow cytometer. Results were analyzed using FlowJo v10.4.2.
Circulating endothelial cells
Circulating endothelial cells (CECs) were identified with CD146-immunomagnetic bead extraction based on an international consensus standardised protocol (Clarke et al, 2010) .
Venous blood (1 ml) collected into tubes containing EDTA was mixed with buffer (1 ml of phosphate buffered saline containing 0.1% bovine serum albumin and 0.6% sodium citrate) and 20 μl of Fc receptor-blocking reagent (Miltenyi Biotec) and incubated for 5 minutes at room temperature. Fifty microliters of a preparation of anti-CD146-coated immunomagnetic beads (clone S-endo-1; BioCytex and Dynal Biotech) was added, and the sample was incubated at 4°C for 30 minutes, with rotation. Bead-bound cells were separated using a magnet (MPC-L; Dynal Biotech) and washed 3 times with buffer. Cells were then resuspended in 100 μl of buffer containing 10 μl of a 2-mg/ml preparation of FITC-labeled Ulex europaeus lectin (Sigma-Aldrich) and incubated for 1 hour at room temperature in the dark. CECs in the sample were counted using a Nageotte chamber on a fluorescence. CECs were defined as Ulex bright cells that were >10 μm in size, with >5 magnetic beads attached.
Vasculitis and Inflammation Panel (VIP) targeted genetic sequencing
Detailed description of the development and validation of this panel and list of genes included in the panel has been described elsewhere in more detail (Omoyinmi et al, 2017) . In brief the capture of targeted genes/regions was performed using the Agilent QXT Target Enrichment system according to the manufacturer's protocol (Version B. 
Myositis specific autoantibody detection
Detection of myositis specific autoantibodies was performed through the routine clinical lab at Great Ormond Street Hospital NHS Foundation Trust using a combination of immunoprecipitation and ELISA (Tansley et al., 2017) . Screening included testing for the antibodies against the following: TIF1γ, OJ, EJ, PL12, PL7, SRP, Jo-1, Pm-Scl75, PmSc1l100, Ku, SAE, NXP-2, MDA5, Mi-2, Ro-52. 
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